Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ARQT compared with PVLA: revenue, margins and what each company keeps, and the suppliers and customers both name
ARQT
Arcutis Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PVLA
Palvella Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ARQT, solid
PVLA, dashed
ARQT
Arcutis Biotherapeutics, Inc.
Change
32.00
▼
−0.21%
Mkt cap
$4.0B
Revenue
$130M
Q2 FY26
Revenue
$376M
FY25
PVLA
Palvella Therapeutics, Inc.
Change
146.23
▲
+0.05%
Regular session
Nov 2 '26
Mkt cap
—
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
ARQT
Arcutis Biotherapeutics, Inc.
vs
PVLA
Palvella Therapeutics, Inc.
32.00
▼
−0.21%
Price
146.23
▲
+0.05%
$4.0B
Mkt cap
—
Q2 FY26
$130M
Revenue
—
FY25
$376M
Revenue
—
Change
Change
ARQT
32.00
▼
−0.21%
vs
PVLA
146.23
▲
+0.05%
Regular session
Nov 2 '26